North Star Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Buy |
+737
| New | +$387K | 0.02% | 250 |
|
|
2024
Q4 | – | Sell |
-277
| Closed | -$291K | – | 331 |
|
|
2024
Q3 | $291K | Hold |
277
| – | – | 0.01% | 263 |
|
|
2024
Q2 | $291K | Sell |
277
-1
| -0.4% | -$1.05K | 0.01% | 259 |
|
|
2024
Q1 | $268K | Hold |
278
| – | – | 0.01% | 269 |
|
|
2023
Q4 | $244K | Hold |
278
| – | – | 0.01% | 269 |
|
|
2023
Q3 | $229K | Buy |
+278
| New | +$229K | 0.01% | 271 |
|
|
2023
Q2 | – | Sell |
-281
| Closed | -$231K | – | 304 |
|
|
2023
Q1 | $231K | Buy |
281
+1
| +0.4% | +$822 | 0.01% | 270 |
|
|
2022
Q4 | $202K | Buy |
+280
| New | +$202K | 0.01% | 290 |
|